Company Details
- Employees
- 15
- Founded
- -
- Address
- Ness Ziona , Il
- Phone
- +972 504057353
- in****@****elf.com
- Industry
- Biotechnology
- Website
- matricelf.com
- HQ
- Ness Ziona
Please complete the CAPTCHA to continue
Related company profiles:
Cellino and Matricelf Announce Global Collaboration to Scale Personalized Spinal Cord Injury Treatments Business Wire
Cellino’s regenerative medicine tie-up with Matricelf is a step forward for longevity Longevity.Technology
The Future of Spinal Cord Injury Treatment: How Cellino and Matricelf Are Leading the Way SynBioBeta
Matricelf is happy to share successful interim results of efficacy preclinical pilot study BioSpace
Matricelf eyes 3D printed human spinal cord trials after curing paralysis in mice 3D Printing Industry
Israeli company Matricelf finishes third in 2022 Startup World Cup CTech
Tel Aviv University researchers engineer human spinal cord implants for treating paralysis Ministry of Foreign Affairs www.gov.il
Matricelf moves closer to curing paralysis with in-house 3D printable human stem cells 3D Printing Industry
Matricelf licenses patent for 3D bioprinting tissues and organs from TAU 3D Printing Industry
Find emails, phones & company data instantly
Your AI prospecting assistant
0 records × $0.02 per record
Secure checkout
Total price
$0.50
Enter your payment details below to complete the download. We'll email you the CSV as soon as it's ready.
Processing your payment...
Please wait while we complete your transaction
Sign in required
Create a free account or sign in to continue downloading the full results.
Sign up for a free account. No credit card required. Up to 10 free credits.
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.